Tata Mutual Fund
← All mutual funds

Tata India Pharma & Healthcare Fund - Direct Plan - Reinvestment of Income Distribution cum capital withdrawal option

Tata Mutual Fund · Sectoral/Thematic · Direct · IDCW

NAV · as of 11/09/2026

37.97

1D

-0.54%

1Y

+5.10%

Key stats

Expense ratio
0.97%
AUM
₹1.57 K Cr
Launched
28/12/2015
Fund manager
Rajat Srivastava
Portfolio turnover
1.04%
Risk
Very High Risk
Min lump-sum
₹5,000
Min SIP
₹100/mo
Fresh lump-sum
Accepted
Fresh SIP
Accepted

NAV history

Tata India Pharma & Healthcare Fund - Direct Plan - Reinvestment of Income Distribution cum capital withdrawal option

13/08/2026 to 11/09/2026

O - H - L -

38.7537.9713/08/202611/09/2026
1W-0.68%
1M-1.75%
3M+6.02%
6M+11.23%
1Y+5.10%
3Y+18.38%
5Y+13.84%
MAX+278.36%

Top holdings

41 disclosed
  • 1.

    Sun Pharmaceuticals Industries Ltd

    Healthcare

    8.59%
  • 2.

    Divi's Laboratories Ltd

    Healthcare

    6.36%
  • 3.

    HealthCare Global Enterprises Ltd

    Healthcare

    5.85%
  • 4.

    Abbott India Ltd

    Healthcare

    5.63%
  • 5.

    Rainbow Childrens Medicare Ltd

    Healthcare

    4.90%
  • 6.

    GlaxoSmithKline Pharmaceuticals Ltd

    Healthcare

    4.66%
  • 7.

    Cipla Ltd

    Healthcare

    4.53%
  • 8.

    Dr Reddy's Laboratories Ltd

    Healthcare

    4.25%
  • 9.

    Max Healthcare Institute Ltd Ordinary Shares

    Healthcare

    4.07%
  • 10.

    Apollo Hospitals Enterprise Ltd

    Healthcare

    3.90%
  • 11.

    Bayer CropScience Ltd

    Basic Materials

    3.26%
  • 12.

    Fortis Healthcare Ltd

    Healthcare

    3.12%
  • 13.

    Pfizer Ltd

    Healthcare

    3.06%
  • 14.

    Mankind Pharma Ltd

    Healthcare

    3.02%
  • 15.

    Syngene International Ltd

    Healthcare

    2.95%
  • 16.

    Sai Life Sciences Ltd

    Healthcare

    2.89%
  • 17.

    Lupin Ltd

    Healthcare

    2.64%
  • 18.

    Alkem Laboratories Ltd

    Healthcare

    2.58%
  • 19.

    Procter & Gamble Health Ltd

    Healthcare

    2.42%
  • 20.

    FDC Ltd

    Healthcare

    2.39%
  • 21.

    Dr. Lal PathLabs Ltd

    Healthcare

    2.17%
  • 22.

    Global Health Ltd

    Healthcare

    2.13%
  • 23.

    Concord Biotech Ltd

    Healthcare

    1.91%
  • 24.

    Sumitomo Chemical India Ltd Ordinary Shares

    Basic Materials

    1.59%
  • 25.

    Ajanta Pharma Ltd

    Healthcare

    1.53%
  • 26.

    Neuland Laboratories Ltd

    Healthcare

    1.25%
  • 27.

    Gillette India Ltd

    Consumer Defensive

    1.15%
  • 28.

    Metropolis Healthcare Ltd

    Healthcare

    1.12%
  • 29.

    Manipal Health Enterprises Ltd

    Healthcare

    0.97%
  • 30.

    BASF India Ltd

    Basic Materials

    0.97%
  • 31.

    Jubilant Pharmova Ltd

    Healthcare

    0.83%
  • 32.

    Dr Agarwal’s Health Care Ltd

    Healthcare

    0.67%
  • 33.

    Cash / Net Current Asset

    0.60%
  • 34.

    Sanofi Consumer Healthcare India Ltd

    Healthcare

    0.55%
  • 35.

    Biocon Ltd

    Healthcare

    0.52%
  • 36.

    Zim Laboratories Ltd Ordinary Shares

    Healthcare

    0.46%
  • 37.

    (I) Treps

    0.26%
  • 38.

    Sanofi India Ltd

    Healthcare

    0.23%
  • 39.

    Anthem Biosciences Ltd

    Healthcare

    0.01%
  • 40.

    Ipca Laboratories Ltd

    -
  • 41.

    Torrent Pharmaceuticals Ltd

    -

Sector allocation

  • Healthcare92.17%
  • Basic Materials5.82%
  • Consumer Defensive1.15%
  • Unclassified0.86%

Comparable peers

  • SBI Healthcare Opportunities IDCW Payout Direct Plan

    SBI Healthcare Opportunities IDCW Payout (DP) · ₹5.40 K Cr AUM

    1Y+22.46%
    3Y+24.66%
    -

  • Tata India Pharma & Healthcare IDCW Payout Direct Plan

    Tata India Pharma & Healthcare IDCW Payout (DP) · ₹1.57 K Cr AUM

    1Y+9.37%
    3Y+19.96%
    -

  • HDFC Transportation & Logistics IDCW Reinvest Direct Plan

    HDFC Transportation & Logistics IDCW Reinvest (DR) · ₹1.96 K Cr AUM

    1Y+9.29%
    3Y+25.53%
    -

  • HDFC Transportation & Logistics IDCW Payout Direct Plan

    HDFC Transportation & Logistics IDCW Payout (DP) · ₹1.96 K Cr AUM

    1Y+9.29%
    3Y+25.53%
    -

  • HDFC Transportation & Logistics IDCW Reinvest Direct Plan

    HDFC Transportation & Logistics IDCW Reinvest (DR) · ₹1.96 K Cr AUM

    1Y+9.29%
    3Y+25.53%
    -

Investment objective

The investment objective of the scheme is to seek long term capital appreciation by investing atleast 80% of its net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.

Scheme details

Scheme code
135808
Fund house
Tata Mutual Fund
Category
Open Ended
Type
Equity Scheme
Sub-category
Sectoral/Thematic
Plan
Direct
Return type
IDCW
ISIN (Growth)
-
ISIN (Div. Reinvest)
INF277K011B8
Tradable on exchange
No

Kuvera page